Salvage Surgery a Possible Approach in NSCLC After Immunotherapy
Written by
American Journal Managed Care
Published
0
comments
0
min
Selected patients with a clinical response after therapy could benefit from salvage surgery in non–small cell lung cancer (NSCLC), with acceptable results for perioperative morbidity.